Sign In
Buy PDCO
$31.33
+0 (+0%)
At Close: Jul 16, 2025
Patterson Companies (PDCO) Inks Deal to Expand Product Suite
09:47am, Friday, 11'th Nov 2022
Patterson Companies' (PDCO) latest buyout is expected to significantly expand its value-add platform.
Patterson Cos. names new CEO, after Mark Walchirk resigns after violating policy, demonstrating poor judgment
09:16am, Thursday, 13'th Oct 2022
Patterson Companies Inc. PDCO, -2.12% said Thursday that is has named Don Zurbay as chief executive officer. Zurbay, who was most recently the dental and animal health company's chief financial office
Reasons to Retain AmerisourceBergen (ABC) in Your Portfolio
04:15pm, Monday, 26'th Sep 2022 Zacks Investment Research
AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
Here's Why Investors Should Hold Myriad Genetics (MYGN) Now
03:35pm, Monday, 26'th Sep 2022 Zacks Investment Research
Myriad Genetics' (MYGN) expansion across the globe, banking on myChoiceCDx test sales, seems impressive.
Patterson Companies: Unfairly Punished, Mispricing Opportunity Ahead
10:58am, Thursday, 22'nd Sep 2022
Patterson Companies has been hammered in H2 2022, nudging 52-week lows following its latest set of numbers. Investors were quick to punish the stock on weaker top-line growth, despite management retai
Patterson Companies: Looking Past The Earnings Disappointment
02:14am, Thursday, 22'nd Sep 2022
Patterson's Q1 2023 earnings report disappointed amid weakness in the dental business. The reiterated guidance indicates continued resilience in animal health, though, with dental also benefiting from
Here's Why You Should Retain Patterson Companies (PDCO) Stock
04:45pm, Thursday, 15'th Sep 2022 Zacks Investment Research
Investors remain optimistic about Patterson Companies (PDCO) on the back of its strong product line.
Here's Why You Should Retain Patterson Companies (PDCO) Stock
04:12pm, Thursday, 15'th Sep 2022
Investors remain optimistic about Patterson Companies (PDCO) on the back of its strong product line.
What 4 Analyst Ratings Have To Say About Patterson Cos
05:34pm, Tuesday, 06'th Sep 2022 Benzinga
Patterson Cos (NASDAQ:PDCO) has observed the following analyst ratings within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
0
3
1
0
0
Last 30
FedEx Faces Price Target Cut By This Analyst; Also Check Out Some Other Major PT Changes
03:23pm, Tuesday, 06'th Sep 2022 Benzinga
Citigroup cut the price target on FedEx Corporation (NYSE: FDX) from $270 to $225. Citigroup analyst Christian Wetherbee also downgraded the stock from Buy to Neutral. FedEx shares fell 3% to trade a
Chemed's (CHE) Roto-Rooter Growth Aids, Macro Challenges Ail
04:46pm, Friday, 02'nd Sep 2022 Zacks Investment Research
Chemed's (CHE) VITAS segment revenue decline during the second quarter gets somewhat offset by a geographically weighted average Medicare reimbursement rate increase of nearly 1.3%.
Haemonetics (HAE) Business Recovery Continues, Macro Issues Ail
04:36pm, Friday, 02'nd Sep 2022 Zacks Investment Research
Despite sluggish results of Haemonetics' (HAE) Blood Center business, Whole Blood revenues grow on favorable order timing among distributors in the Asia Pacific and EMEA.
Company News for Sep 2, 2022
01:31pm, Friday, 02'nd Sep 2022 Zacks Investment Research
Companies in The News Are:CIEN,OLLI,SAIC,PDCO
This Analyst Predicts $700 For Broadcom, Plus RBC Capital Slashes PT On This Stock By 85%
12:38pm, Friday, 02'nd Sep 2022 Benzinga
Keybanc cut the price target for Broadcom Inc. (NASDAQ: AVGO) from $780 to $700. Broadcom shares rose 2.3% to $503.14 in pre-market trading.
UBS reduced the price target on Peloton Interactive, Inc
Here's Why You Should Hold on to Chemed (CHE) Stock Now
04:52pm, Thursday, 01'st Sep 2022 Zacks Investment Research
Investors are optimistic about Chemed's (CHE) better-than-expected earnings and impressive Roto-Rooter results.
